About us
our network
V.A. Cure is an EU-MSCA-ITN project that started on 1 March 2019. The project comprises research, training and networking, with as main goals: to develop new therapies for vascular anomalies and to train a next generation of highly skilled vascular biologists
V.A. Cure brings together 7 leading academic research groups in the field of vascular biology and 2 highly innovative companies, complemented with 8 partner organisations. Together we cover the whole innovation chain from patient to bench and back to the patient.
The Consortium
Our consortium consists of 7 academic groups and 2 companies. They host and supervise the 14 research projects:
de Duve Institute, Brussels, Belgium (coordinator). PI: Prof. Miikka Vikkula
Uppsala University, Uppsala, Sweden. PI: Prof. Taija Makinen
University of Oulu, Oulu, Finland. PI: Prof. Lauri Eklund
Karolinska Institute, Stockholm, Sweden. PI: Prof. Lars Jakobsson
Max Planck Institute for Heart and Lung Research, Berlin, Germany. PI: Prof. Michael Potente
University of Potsdam, Potsdam, Germany. PI: Prof. Salim Seyfried
INSERM U1036, Grenoble, France. PI: Prof. Sabine Bailly
AstraZeneca, Götenborg, Sweden. PI’s: John Wiseman and Ryan Hicks
FinnAdvance, Oulu, Finland. PI: Prateek Singh
Contact Info
The V.A. Cure project is coordinated by de Duve Institute
Address
Avenue Hippocrate 75, 1200 Brussels, Belgium
Project assistent
Francisca Voermans
Email Us
Francisca.Voermans@uclouvain.be